Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportPoster - PhysicianPharm

Comparison of regadenoson and dypiridamole myocardial blood flow and coronary flow reserve hyperemic response by non-invasive quantitative N-13 ammonia PET.

Thuy Nguyen, David Lin, Donald Grandis, Atif Qasim and Miguel Hernandez Pampaloni
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 1653;
Thuy Nguyen
1University of California, San Francisco San Francisco CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Lin
1University of California, San Francisco San Francisco CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Donald Grandis
1University of California, San Francisco San Francisco CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Atif Qasim
1University of California, San Francisco San Francisco CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miguel Hernandez Pampaloni
1University of California, San Francisco San Francisco CA United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1653

Introduction: Regadenoson is currently the most commonly used drug for pharmacologic stress myocardial perfusion imaging. Given its more selective A2A agonist-driven vasodilatory properties when compared to adenosine or dipyridamole, the accuracy of measuring true hyperemia after the standard bolus of N-13 ammonia injection remains to be fully established. Our aim was to use quantitative N-13 ammonia PET myocardial perfusion for assessing myocardial blood flow (MBF) and coronary flow reserve (CFR) response to regadenoson (REG) and dipyridamole (DIP) in patients with an intermediate pre-test likelihood of coronary artery disease (CAD). We hypothesized that the global flow response to regadenoson is comparable to that with dipyridamole. Additionally, we sought to determine whether the magnitude of the flow response to regadenoson is influenced by the lack of weight adjustment of the injected dose, and from the physical characteristics of N-13 ammonia myocardial pharmacodynamics. To avoid interfering effects from flow-limiting coronary artery stenosis, 45 patients (23 REG, 22 DIP) with normal left ventricular ejection fraction (LVEF >45%) on PET scan and no prior history of overt disease CAD were included in the study. Patients with cardiomyopathy, prior myocardial infarction, or elevated coronary calcium score (CAC > 400) were also excluded from the study. Standard dynamic PET images were acquired after 20 mCi of N-13 ammonia at rest and following the clinical standard administration of regadenoson or dipyridamole. Myocardial vascular resistance was similar between groups at rest (137 ± 36 vs. 140±51 mmHg/ml/min/g for REG and DIP respectively) or in response to the vasodilator (49±22 for REG vs. 48±26 mmHg/ml/min/g for DIP). Overall hemodynamic changes were similar with comparable rest and hyperemic global myocardial blood flow (rest REG and DIP 1.01±0.25, 0.92±0.18 mL/g,/min respectively; hyperemic REG and DIP 2.4±0.81, 2.42±1.14 mL/g/min respectively). CFR remains similar between both agents (REG 2.45±0.68, DIP 2.47±0.85). These results indicate that regadenoson provides similar hyperemic myocardial blood flow changes than pure vasodilator agents when using N-13 ammonia PET imaging.

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 62, Issue supplement 1
May 1, 2021
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comparison of regadenoson and dypiridamole myocardial blood flow and coronary flow reserve hyperemic response by non-invasive quantitative N-13 ammonia PET.
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Comparison of regadenoson and dypiridamole myocardial blood flow and coronary flow reserve hyperemic response by non-invasive quantitative N-13 ammonia PET.
Thuy Nguyen, David Lin, Donald Grandis, Atif Qasim, Miguel Hernandez Pampaloni
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 1653;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Comparison of regadenoson and dypiridamole myocardial blood flow and coronary flow reserve hyperemic response by non-invasive quantitative N-13 ammonia PET.
Thuy Nguyen, David Lin, Donald Grandis, Atif Qasim, Miguel Hernandez Pampaloni
Journal of Nuclear Medicine May 2021, 62 (supplement 1) 1653;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Poster - PhysicianPharm

  • Preliminary result of Texture Analysis on prediction of overall outcome of neuroendocrine tumors based on pre-therapy heterogeneity of somatostatin receptors on 68Ga Dotatate PET/CT scans.
  • Chemokine receptor 2 targeted PET imaging in pulmonary fibrosis.
  • Comparison of FDG PET/CT and bone marrow biopsy results in patients with diffuse large B cell lymphoma with subgroup analysis of PET radiomics
Show more Poster - PhysicianPharm

Clinical Science

  • Metabolic alternation in brain in patients with ischemic heart failure: A prospective outcome study
  • Coronary artery disease and risk in breast cancer patients identified with FDG PET-CT
  • Ammonia PET-derived Right Ventricular Strain: Prognostic Value in Coronary Artery Disease
Show more Clinical Science

Similar Articles

SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire